The U.S. has adopted a new policy recommending hepatitis B vaccination at birth only for high-risk infants, projected to increase infant infections and chronic cases in children, adding millions to healthcare costs. This shift impacts public health strategies and could strain resources for managing preventable diseases. Historically high levels of maternal screening or targeted vaccine coverage will be necessary to mitigate the rise in neonatal infections.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



